Рет қаралды 17,578
Join Drs. Gregory Cosgrove and Jonathan Chung as they discuss the HRCT features and patterns associated with a progressive phenotype in patients with chronic fibrosing interstitial lung disease. This presentation is sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.